'Molecular target' presentation slideshows

T-Cells NK

T-Cells NK . Feb 13, 2006. T-cells. Antigens that are transported by dendritic cells to lymph nodes are recognized by naive T lymphocytes that recirculate through these lymph nodes.

961 views • 61 slides

Tumour growth is angiogenesis dependent Judah Folkman 1971

Meta-analyses confirm survival benefit with chemotherapy 1990s. Tumour growth is angiogenesis dependent Judah Folkman 1971. Routine identification of EGFR mut+ve & TKIs therapy 2010-11. Discovery of cisplatin 1965. Discovery of paclitaxel 1967. VEGF gene identified

567 views • 40 slides

Outline

Elevated Beclin 1 expression is correlated with HIF-1α in predicting poor prognosis of nasopharyngeal carcinoma.

489 views • 31 slides

IPF: How to approach the search for new therapies

IPF: How to approach the search for new therapies. Peter Bitterman MD Research Director, Lillehei Heart Institute Professor of Medicine University of Minnesota. What is wrong in IPF?. What appears to be normal scar tissue is deposited in the gas exchange surface of the lung.

326 views • 26 slides

ANTICANCER THERAPY

ANTICANCER THERAPY. PART III. ILOs. Encompass how some hormones and antihormones are utilized as anticancer therapy Identify concept of immunomodulation as an anticancer treatment modality

651 views • 23 slides

Molecular Targets Development Program, CCR, NCI

Molecular Targets Development Program, CCR, NCI. Translational Research at the CCR. Genetics & Genomics. Integrated Systems Biology. Molecular Targets & Molecular Oncology. CCR Clinical Program. HIV/AIDS. Immunology, Immunotherapy & Immunoprophylaxis. Intramural/Extramural.

414 views • 13 slides

Aarkstore Market Research Report - Frontier Pharma Prostate

The prostate cancer pipeline is among the largest in the pharmaceutical industry with 484 products in active development across all stages. For More Details: http://goo.gl/cIMtf5

275 views • 13 slides

Aarkstore - Frontier Pharma: Alzheimers Disease - Identifyin

223 views • 10 slides

Transplantation therapeutics Global Market Forecast

Frontier Pharma: Transplantation Therapeutics-A Highly Innovative Pipeline with a Range of Adaptive and Innate Immune-Targeting Programs Focusing on Graft-Versus-Host Disease and Kidney Transplantation

95 views • 9 slides

Pain-Identifying and Commercializing First-in-Class Innovati

174 views • 8 slides

Global Viral Infections Market to 2021 - Key players, Attractiveness, Competitive Landscape and Forecasts

159 views • 7 slides

Psoriasis - Identifying and Commercializing First-in-Class I

168 views • 6 slides

Frontier Pharma-Obesity Identifying and Commercializing First-in-Class Innovation

144 views • 5 slides

Ovarian Cancer Market Forecast & Future Industry Trends

Ovarian cancer is the sixth most common cancer in females and it also has the highest mortality rate of gynecological cancers. The five-year survival rate is approximately 45%, although the disease is ultimately fatal in the majority of patients due to a high rate of recurrence.

178 views • 5 slides

Future Market Trends of Ovarian Cancer Market Till 2020

Ovarian cancer is the sixth most common cancer in females and it also has the highest mortality rate of gynecological cancers. The five-year survival rate is approximately 45%, although the disease is ultimately fatal in the majority of patients due to a high rate of recurrence.

166 views • 5 slides

Modulation of Apoptosis by active compounds for cancer therapy

Modulation of Apoptosis by active compounds for cancer therapy. Organ Site Molecular target. Modulation of Apoptosis by active compounds for cancer therapy. Organ Site Molecular target. Modulation of Apoptosis by active compounds for cancer therapy. Organ Site Molecular target.

97 views • 3 slides